$495 Million Verdict Against Abbott Laboratories Set to Shape NEC Baby Formula Litigation Nationwide July 28, 2024 A widely anticipated necrotizing enterocolitis (NEC) baby formula trial concluded with a $495 million judgment on Friday against Abbott Laboratories. This is the second plaintiff verdict in recent trials aimed at resolving baby formula manufacturers’ liability for their products causing preterm babies to develop a serious condition in which bowel tissue dies. In March, a […] Read More
$60 Million Verdict in Enfamil Baby Formula NEC Case Underscores Need for Transparency and Accountability March 22, 2023 An Illinois jury has awarded $60 million to the plaintiff in the first in a series of trials out of hundreds of baby formula necrotizing enterocolitis (NEC) lawsuits claiming that various Enfamil and Abbott Laboratories’ Similac formulas caused necrotizing enterocolitis (NEC). Plaintiffs in this multidistrict litigation claim that the companies hid the information that their formula, including […] Read More
FDA Sends Letter Calling for Improved Baby Formula Practices March 21, 2023 In early March, the U.S. Food and Drug Administration (FDA) sent a letter to members of the infant formula supply chain. The FDA called on recipients—including manufacturers, distributors, and others, to notify the agency if bacterial pathogens have been detected in their baby formula product samples and to beef up safety practices to prevent and […] Read More